Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 14.39
(-0.41%)
CNY 14.39
(-0.41%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.52 Billion CNY | 0.53% |
| 2022 | 5.44 Billion CNY | 34.01% |
| 2021 | 4.06 Billion CNY | 53.48% |
| 2020 | 2.64 Billion CNY | 31.26% |
| 2019 | 2.01 Billion CNY | 8.3% |
| 2018 | 1.86 Billion CNY | 8.43% |
| 2017 | 1.71 Billion CNY | 3.89% |
| 2016 | 1.65 Billion CNY | 14.45% |
| 2015 | 1.44 Billion CNY | 12.31% |
| 2014 | 1.28 Billion CNY | -1.79% |
| 2013 | 1.3 Billion CNY | 14.53% |
| 2012 | 1.14 Billion CNY | 22.28% |
| 2011 | 935.11 Million CNY | 12.21% |
| 2010 | 833.37 Million CNY | 27.72% |
| 2009 | 652.52 Million CNY | 10.47% |
| 2008 | 590.66 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.27 Billion CNY | -12.25% |
| 2024 Q3 | 1.2 Billion CNY | -5.96% |
| 2024 Q1 | 1.45 Billion CNY | 56.5% |
| 2023 Q2 | 1.5 Billion CNY | -14.15% |
| 2023 FY | 5.47 Billion CNY | 0.53% |
| 2023 Q3 | 1.32 Billion CNY | -12.07% |
| 2023 Q4 | 929.95 Million CNY | -29.65% |
| 2023 Q1 | 1.75 Billion CNY | 63.3% |
| 2022 Q1 | 1.37 Billion CNY | 29.72% |
| 2022 FY | 5.44 Billion CNY | 34.01% |
| 2022 Q4 | 1.07 Billion CNY | -24.38% |
| 2022 Q3 | 1.41 Billion CNY | -10.29% |
| 2022 Q2 | 1.58 Billion CNY | 15.08% |
| 2021 Q2 | 1.01 Billion CNY | 18.21% |
| 2021 FY | 4.06 Billion CNY | 53.48% |
| 2021 Q3 | 1.13 Billion CNY | 12.26% |
| 2021 Q4 | 1.05 Billion CNY | -6.79% |
| 2021 Q1 | 856.09 Million CNY | -5.03% |
| 2020 Q1 | 391.51 Million CNY | -40.55% |
| 2020 Q3 | 737.87 Million CNY | 19.7% |
| 2020 Q4 | 901.44 Million CNY | 22.17% |
| 2020 FY | 2.64 Billion CNY | 31.26% |
| 2020 Q2 | 616.45 Million CNY | 57.46% |
| 2019 Q1 | 397.9 Million CNY | -32.93% |
| 2019 FY | 2.01 Billion CNY | 8.3% |
| 2019 Q4 | 658.54 Million CNY | 31.61% |
| 2019 Q3 | 500.39 Million CNY | 8.79% |
| 2019 Q2 | 459.96 Million CNY | 15.6% |
| 2018 Q1 | 475.47 Million CNY | -1.59% |
| 2018 FY | 1.86 Billion CNY | 8.43% |
| 2018 Q4 | 593.28 Million CNY | 69.84% |
| 2018 Q3 | 349.31 Million CNY | -21.35% |
| 2018 Q2 | 444.14 Million CNY | -6.59% |
| 2017 Q4 | 483.14 Million CNY | 10.83% |
| 2017 Q2 | 403.79 Million CNY | 2.34% |
| 2017 Q1 | 394.55 Million CNY | -14.5% |
| 2017 Q3 | 435.94 Million CNY | 7.96% |
| 2017 FY | 1.71 Billion CNY | 3.89% |
| 2016 Q1 | 351.02 Million CNY | -4.36% |
| 2016 FY | 1.65 Billion CNY | 14.45% |
| 2016 Q4 | 461.44 Million CNY | 6.25% |
| 2016 Q3 | 434.3 Million CNY | 6.86% |
| 2016 Q2 | 406.4 Million CNY | 15.78% |
| 2015 Q2 | 364.87 Million CNY | 8.25% |
| 2015 Q1 | 337.05 Million CNY | -4.94% |
| 2015 FY | 1.44 Billion CNY | 12.31% |
| 2015 Q4 | 367.02 Million CNY | -2.27% |
| 2015 Q3 | 375.55 Million CNY | 2.93% |
| 2014 Q1 | 298.39 Million CNY | 0.33% |
| 2014 FY | 1.28 Billion CNY | -1.79% |
| 2014 Q2 | 341.16 Million CNY | 14.33% |
| 2014 Q4 | 354.56 Million CNY | 21.39% |
| 2014 Q3 | 292.08 Million CNY | -14.39% |
| 2013 Q3 | 332.27 Million CNY | 0.0% |
| 2013 FY | 1.3 Billion CNY | 14.53% |
| 2013 Q4 | 297.4 Million CNY | -10.49% |
| 2012 FY | 1.14 Billion CNY | 22.28% |
| 2011 FY | 935.11 Million CNY | 12.21% |
| 2010 FY | 833.37 Million CNY | 27.72% |
| 2009 FY | 652.52 Million CNY | 10.47% |
| 2008 FY | 590.66 Million CNY | 0.0% |